SCHEMBL7988030

SCHEMBL7988030

Cn1cc(C2=C(c3cn(C)c4cc([N+](=O)[O-])ccc34)C(=O)NC2=O)c2ccc(N3CCCC3)cc21

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDK4 P11802 2/20 0.45
CCND1 P24385 2/20 0.45
CDK2 P24941 2/20 0.45
CCNE2 O96020 1/20 0.45
CCNE1 P24864 1/20 0.45
MAPT P10636 2/20 0.43
JAK3 P52333 1/20 0.43
GSK3A P49840 2/20 0.42
GSK3B P49841 2/20 0.42
MEN1 O00255 1/20 0.42
RGS12 O14924 1/20 0.42
GMNN O75496 1/20 0.42
USP2 O75604 1/20 0.42
CCNB2 O95067 1/20 0.42
LMNA P02545 1/20 0.42
TP53 P04637 1/20 0.42
CYP1A2 P05177 1/20 0.42
CDK1 P06493 1/20 0.42
POLB P06746 1/20 0.42
CYP3A4 P08684 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7988067 0.91 GSK3B (0.39) CDK4CCND1CDK2CCNE2CCNE1
SCHEMBL7976559 0.91 GSK3B (0.53) CDK4CCND1CDK2CCNE2CCNE1
SCHEMBL7599053 0.91 CCNE2 (0.51) CDK4CCND1CDK2CCNE2CCNE1
SCHEMBL668748 0.88 CCNE2 (0.57) CDK4CCND1CDK2CCNE2CCNE1
SCHEMBL7976776 0.84 CDK4 (0.67) CDK4CCND1CDK2CCNE2CCNE1
SCHEMBL7508119 0.83 CCNE2 (0.56) CDK4CCND1CDK2CCNE2CCNE1
SCHEMBL7987101 0.83 CDK4 (0.66) CDK4CCND1CDK2CCNE2CCNE1
SCHEMBL7529269 0.83 GSK3B (0.54) CDK4CCND1CDK2CCNE2CCNE1
SCHEMBL7524580 0.83 GSK3B (0.58) CDK4CCND1CDK2CCNE2CCNE1
SCHEMBL7497956 0.82 GSK3B (0.57) CDK4CCND1CDK2CCNE2CCNE1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6281356-B1 ANTICANRCER AGENTS HOFFMANN-LA ROCHE INC. 2001-08-28 US claimed
US-6281356-B1 ANTICANRCER AGENTS HOFFMANN-LA ROCHE INC. 2001-08-28 US disclosed